|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||
| Investments held in Trust Account | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Investments held in Trust Account | ||||||||||||||||||
| Total Assets | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||
| Due to related party | ||||||||||||||||||
| Promissory note – related party | ||||||||||||||||||
| Related Party | ||||||||||||||||||
| Total promissory note – related party | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred underwriting fee payable | ||||||||||||||||||
| Total Liabilities | ||||||||||||||||||
| Class A ordinary shares subject to possible redemption, no par value; 43,594 shares and 43,594 shares at redemption value of $12.247 and $12.096 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||
| Total class A ordinary shares subject to possible redemption, no par value; 43,594 shares and 43,594 shares at redemption value of $12.247 and $12.096 per share as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Shareholders’ Deficit | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total Shareholders’ Deficit | ||||||||||||||||||
| Total Liabilities, Shares Subject to Redemption, and Shareholders’ Deficit | ||||||||||||||||||
Loading...
